Biotech Values

[genisi]

GIVN falls 17% today, due to another lackluster earnings report and a neative announcement on PillCam COLON 2 regulatory path:

Given Imaging has completed the 885-patient PillCam COLON 2 clinical trial for submission to the U.S. Food and Drug Administration (FDA). In the Company's view, its analysis of the data from the PillCam COLON 2 clinical trial in the U.S. support an FDA submission for visualization of the colon in patients who are unable to undergo colonoscopy or in cases of incomplete colonoscopies, rather than a submission for general screening.

http://finance.yahoo.com/news/given-imaging-reports-second-quarter-203000566.html